Physician profile
Christopher Alexander Puchi
NPI 1215564174
$3,982.73
in general payments reported to CMS, 2019-2025
11 companies · $2,021 in 2025
The $2,021 reported for 2025 was more than what 89% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $137 · 2023: $1,037 · 2024: $787 · 2025: $2,021.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,601 · Travel and Lodging: $1,245.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,600.62 |
| Travel and Lodging | $1,244.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $1,878.22 | 2023-2025 | Inspire |
| Medtronic, INC. | $360.44 | 2023-2024 | Sinuva, Pteye Parathyroid Detection System |
| Axogen | $348.23 | 2023 | Avance Nerve Graft |
| Acera Surgical, INC. | $294.10 | 2024-2025 | Restrata Wound Matrix |
| Ambu INC. | $220.43 | 2024 | |
| Stryker Corporation | $208.58 | 2023-2025 | Na, Hydroset, Adherus Autospray Et Dural Sealant |
| Aerin Medical INC. | $159.43 | 2023 | |
| Polynovo North America LLC | $155.37 | 2024 | Novosorb Btm |
| Integra Lifesciences Corporation | $137.47 | 2022 | |
| Acclarent, INC | $121.65 | 2023 | Trudi Nav Cable |
| Regeneron Healthcare Solutions, INC. | $98.81 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Puchi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.